Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FY9DR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,445
Award facts
- Contract value 100% obligated
- $21,444.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Renflexis 100 mg vials, with a ceiling value of $21,444.63 and an ultimate completion date of August 12, 2025. This non-set-aside contract represents a direct fulfillment of pharmaceutical needs through the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and veteran healthcare systems through competitively awarded contracts with the Defense Logistics Agency.
This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime IDC vehicle, this contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The Renflexis vials procurement supports the Defense Health Agency and other government healthcare systems requiring biosimilar therapeutic options for their patient populations.
Quick answers
Who was awarded contract SPE2DB25FY9DR?
SPE2DB25FY9DR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FY9DR worth?
The government has obligated $21,445 on SPE2DB25FY9DR.
Is contract SPE2DB25FY9DR an order under another contract?
Yes. SPE2DB25FY9DR is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9DR competed?
The extent of competition for SPE2DB25FY9DR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award